SCHEMBL2178288

SCHEMBL2178288

COc1ccc2cc(-c3ccnc(NCc4cccnc4)n3)cc(N3CCOCC3)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 1/20 0.48
SMG1 Q96Q15 1/20 0.48
CLK4 Q9HAZ1 6/20 0.48
CLK1 P49759 5/20 0.48
DYRK1A Q13627 5/20 0.48
CDK2 P24941 3/20 0.48
CLK2 P49760 3/20 0.48
DYRK1B Q9Y463 3/20 0.48
CLK3 P49761 2/20 0.48
PIK3CA P42336 1/20 0.47
RAD52 P43351 1/20 0.46
MKNK1 Q9BUB5 4/20 0.46
HDAC3 O15379 1/20 0.45
NCOR1 O75376 1/20 0.45
HDAC2 Q92769 1/20 0.45
CYP1A2 P05177 3/20 0.45
CYP3A4 P08684 3/20 0.45
CYP2D6 P10635 3/20 0.45
CYP2C19 P33261 3/20 0.45
CYP2C9 P11712 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2178720 0.93 PIK3CA (0.50) MTORSMG1CDK2PIK3CARAD52
SCHEMBL2178166 0.91 DYRK1A (0.52) MTORSMG1CLK4CLK1DYRK1A
SCHEMBL2181055 0.90 CLK4 (0.48) CLK4CLK1DYRK1ACDK2CLK2
SCHEMBL2179063 0.90 DYRK1A (0.53) MTORSMG1CLK4CLK1DYRK1A
SCHEMBL2179106 0.86 DYRK1A (0.52) MTORSMG1CLK4CLK1DYRK1A
SCHEMBL2181493 0.85 MTOR (0.47) MTORSMG1CLK4CLK1DYRK1A
SCHEMBL2177503 0.85 PIK3CA (0.47) MTORSMG1CLK4CLK1DYRK1A
SCHEMBL2178485 0.84 MKNK1 (0.45) MTORSMG1CLK4CLK1DYRK1A
SCHEMBL2176999 0.84 SMG1 (0.47) MTORSMG1CLK4CLK1DYRK1A
SCHEMBL2177110 0.84 MKNK1 (0.47) MTORSMG1CLK4CLK1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US claimed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP MTOR 917/4885SMG1 1349/4885CLK4 3301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.